Publication: A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)
Date
Authors
Gürel, S.
Authors
Yurdaydın, Cihan
Wedemeyer, Heiner
Dalekos, George
Erhardt, Alexander
Çakaloğlu, Y.
Değertekin, H.
Zeuzem, Stefan
Zachou, Kalliopi
Bozkaya, Hakan
Advisor
Language
Type
Publisher:
Wiley
Journal Title
Journal ISSN
Volume Title
Abstract
Description
Bu çalışma, 27-31 Ekim 2006 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 57. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.
Source:
Keywords:
Keywords
Gastroenterology & hepatology
Citation
Yurdaydın, C. vd. (2006). ''A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)''. Hepatology, 44(4), Suplement 1, 230A-230A.